Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

I. Vaxman; S. K. Kumar; F. Buadi; M. Q. Lacy; D. Dingli; S. Hayman; T. Kourelis; R. Warsame; Y. Hwa; A. Fonder; M. Hobbs; E. Muchtar; N. Leung; P. Kapoor; R. Go; Y. Lin; W. Gonsalves; M. Siddiqui; R. A. Kyle; S. V. Rajkumar; M. A. Gertz; A. Dispenzieri

doi:10.1038/s41408-023-00859-x

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

I. Vaxman, S. K. Kumar, F. Buadi, M. Q. Lacy, D. Dingli, S. Hayman, T. Kourelis, R. Warsame, Y. Hwa, A. Fonder, M. Hobbs, E. Muchtar, N. Leung, P. Kapoor, R. Go, Y. Lin, W. Gonsalves, M. Siddiqui, R. A. Kyle, S. V. RajkumarM. A. Gertz, A. Dispenzieri^*

^*Corresponding author for this work

Oncology

Research output: Contribution to journal › Letter › peer-review

10 Scopus citations

Original language	English
Article number	91
Journal	Blood Cancer Journal
Volume	13
Issue number	1
DOIs	https://doi.org/10.1038/s41408-023-00859-x
State	Published - Dec 2023

Funding

Funders	Funder number
Predolin Foundation
National Cancer Institute
Jabbs Foundation

Access to Document

10.1038/s41408-023-00859-x

Cite this

Vaxman, I., Kumar, S. K., Buadi, F., Lacy, M. Q., Dingli, D., Hayman, S., Kourelis, T., Warsame, R., Hwa, Y., Fonder, A., Hobbs, M., Muchtar, E., Leung, N., Kapoor, P., Go, R., Lin, Y., Gonsalves, W., Siddiqui, M., Kyle, R. A., ... Dispenzieri, A. (2023). Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience. Blood Cancer Journal, 13(1), Article 91. https://doi.org/10.1038/s41408-023-00859-x

@article{8c5540edf18a4e1b88b207610b0e0665,

title = "Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience",

author = "I. Vaxman and Kumar, {S. K.} and F. Buadi and Lacy, {M. Q.} and D. Dingli and S. Hayman and T. Kourelis and R. Warsame and Y. Hwa and A. Fonder and M. Hobbs and E. Muchtar and N. Leung and P. Kapoor and R. Go and Y. Lin and W. Gonsalves and M. Siddiqui and Kyle, {R. A.} and Rajkumar, {S. V.} and Gertz, {M. A.} and A. Dispenzieri",

note = "Funding Information: This project was supported in part by Grant Number P30 CA015083 and CA186781 from the National Cancer Institute and by the Predolin Foundation and the JABBS Foundation. ",

year = "2023",

month = dec,

doi = "10.1038/s41408-023-00859-x",

language = "אנגלית",

volume = "13",

journal = "Blood Cancer Journal",

issn = "2044-5385",

publisher = "Nature Publishing Group",

number = "1",

}

Vaxman, I, Kumar, SK, Buadi, F, Lacy, MQ, Dingli, D, Hayman, S, Kourelis, T, Warsame, R, Hwa, Y, Fonder, A, Hobbs, M, Muchtar, E, Leung, N, Kapoor, P, Go, R, Lin, Y, Gonsalves, W, Siddiqui, M, Kyle, RA, Rajkumar, SV, Gertz, MA & Dispenzieri, A 2023, 'Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience', Blood Cancer Journal, vol. 13, no. 1, 91. https://doi.org/10.1038/s41408-023-00859-x

TY - JOUR

T1 - Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome

T2 - The Mayo Clinic Experience

AU - Vaxman, I.

AU - Kumar, S. K.

AU - Buadi, F.

AU - Lacy, M. Q.

AU - Dingli, D.

AU - Hayman, S.

AU - Kourelis, T.

AU - Warsame, R.

AU - Hwa, Y.

AU - Fonder, A.

AU - Hobbs, M.

AU - Muchtar, E.

AU - Leung, N.

AU - Kapoor, P.

AU - Go, R.

AU - Lin, Y.

AU - Gonsalves, W.

AU - Siddiqui, M.

AU - Kyle, R. A.

AU - Rajkumar, S. V.

AU - Gertz, M. A.

AU - Dispenzieri, A.

N1 - Funding Information: This project was supported in part by Grant Number P30 CA015083 and CA186781 from the National Cancer Institute and by the Predolin Foundation and the JABBS Foundation.

PY - 2023/12

Y1 - 2023/12

UR - http://www.scopus.com/inward/record.url?scp=85160652270&partnerID=8YFLogxK

U2 - 10.1038/s41408-023-00859-x

DO - 10.1038/s41408-023-00859-x

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 37253713

AN - SCOPUS:85160652270

SN - 2044-5385

VL - 13

JO - Blood Cancer Journal

JF - Blood Cancer Journal

IS - 1

M1 - 91

ER -

Daratumumab, carfilzomib, and pomalidomide for the treatment of POEMS syndrome: The Mayo Clinic Experience

Funding

Access to Document

Other files and links

Cite this